US equities |
GOOGL $285.77 ▼-12.04% GOOG $283.58 ▼-11.90% MSFT $524.29 ▼-1.27% MU $955.90 ▼-2.78% AMZN $246.19 ▼-3.30% META $623.94 ▲+1.87% NVDA $213.86 ▼-0.71% AAPL $350.06 ▲+1.81%
FinancialContent

Haemonetics Corporation Common Stock (NY:HAE)

119.30 +0.98 (+0.82%)
Delayed Quote Updated: 10:19 AM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Haemonetics Corporation Common Stock

News headline image
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
News headline image
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
News headline image
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
From Aligos Therapeutics
Via GlobeNewswire
Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
Via Investor Brand Network
Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
Via Investor Brand Network
News headline image
Sotera Health Appoints Christopher Simon to the Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
News headline image
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023 
Via MarketBeat